Added to YB: 2024-05-24
Pitch date: 2024-04-20
CERT [bullish]
Certara, Inc.
-58.59%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Certara, Inc., together with its subsidiaries, provides technology-enabled services and software products for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access.
Market Cap
$1.1B
Pitch Price
$16.06
Price Target
N/A
Dividend
N/A
EV/EBITDA
10.69
P/E
97.87
EV/Sales
2.87
Sector
Health Care Technology
Category
growth
Show full summary:
The London Company Small Cap Strategy New Portfolio Holding: Certara, Inc.
CERT: Biosim leader w/ 50%+ rev from 39/40 top biopharmas. High-margin recurring revs, Simcyp the gold std. Mid-teens% biosim mkt growth tailwind. Strong b/s & cash flow gen. Low disruption risk.
Read full article (1 min)